Study links mutations in protein to rare blood vessel condition

07/23/2009 | U.S. News & World Report

Canadian researchers said they identified genetic variations in thrombomodulin, a protein that plays a role in blood coagulation and preventing cell damage, that appear to increase the risk of atypical hemolytic-uremic syndrome. The findings could pave the way for treatments for aHUS, a rare blood vessel disorder caused by damage to endothelial cells, the lead researcher said.

View Full Article in:

U.S. News & World Report

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA